Preamendments Class III devices
This article was originally published in The Gray Sheet
FDA proposes in the Aug. 18 Federal Register to require premarket approval applications or product development protocols for lung water monitors, powered vaginal muscle stimulators for therapeutic use and stairclimbing wheelchairs. Written comments are due Nov. 16. The agency is also soliciting new information, due Sept. 2, that would justify reclassifying the devices. FDA says that it intends to require regulatory submissions within 90 days of the effective date of the final rule
You may also be interested in...
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.